Aadi Bioscience is a biopharmaceutical company working on precision therapies for genetically defined cancers. Their lead drug candidate, FYARRO, is being evaluated as a form of sirolimus bound to albumin. The company is headquartered in Pacific Palisades, California and was incorporated in 2007.